Correction to: Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid

Correction to: Predictive and prognostic value of ¹⁸F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid

Ann Nucl Med. 2018 Jul;32(6):430. doi: 10.1007/s12149-018-1265-9.

¹ Clinic of Radiology and Nuclear Medicine, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland. federico.caobelli@usb.ch.
² Nuclear Medicine Unit, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
³ IRCCS Neuromed, Pozzilli (IS), Italy.
⁴ Radiotherapy and Nuclear Medicine Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
⁵ Department of Nuclear Medicine, State University Milan, Milan, Italy.
⁶ Department of Nuclear Medicine, S Orsola-Malpighi University Hospital, Bologna, Italy.
⁷ Nuclear Medicine Department, Hospital of Trento, Trento, Italy.
⁸ San Raffaele G. Giglio Institute, Cefalù, PA, Italy.

The following affiliation should be added to the authors Agostino Chiaravalloti and Orazio Schillaci.